BN Business News
Add your company to Business Communicator →

Business · 23/10/20261 min read

ImmVira presents clinical data from three bladder cancer studies at ESMO 2026

Summary

SUZHOU, China, Oct. 22, 2026 — ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its leading oncolytic immunotherapy candidate, MVR-T3011, will be pre...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →